Quick Answer
P3 Health Partners Inc. reported Net Income Loss of -$147.95 million for the year ending 2025.
- P3 Health Partners Inc. showed a decrease of -8.9% in Net Income Loss from 2024 to 2025.
- This data is from P3 Health Partners Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $0.00 | Q1 2021: -$24.65 million | Q2 2021: -$29.46 million | Q3 2021: -$32.05 million | Q1 2022: -$10.58 million | Q2 2022: -$154.35 million | Q3 2022: -$11.17 million | Q1 2023: -$9.20 million | Q2 2023: -$9.82 million | Q3 2023: -$13.30 million | Q1 2024: -$18.70 million | Q2 2024: -$12.02 million | Q3 2024: -$46.51 million | Q1 2025: -$20.48 million | Q2 2025: -$20.36 million | Q3 2025: -$31.59 million.
- Over the full 8 years of available data (2019 to 2025), P3 Health Partners Inc.'s Net Income Loss has declined by 252.5%.
- Historical annual values: Fiscal year 2025: -$147.95 million | Fiscal year 2024: -$135.85 million | Fiscal year 2023: -$57.77 million | Fiscal year 2022: -$270.13 million | Fiscal year 2021: -$10.08 million | Fiscal year 2021: -$146.40 million | Fiscal year 2020: -$31.41 million | Fiscal year 2019: -$41.97 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: